Oncology Practice63% of patients with upper tract urothelial carcinoma respond to chemo before surgeryFebruary 24, 2022Genitourinary Cancer
Oncology PracticeMRI far safer than CT for guiding radiotherapy in prostate cancerFebruary 24, 2022Genitourinary CancerProstate Cancer
Oncology PracticeTwitter storm over ‘reprehensible behavior’ at conference podiumFebruary 22, 2022Genitourinary Cancer
Oncology Practice“I didn’t want to meet you.” Dispelling myths about palliative careFebruary 2, 2022Patient & Survivor CarePreventive CareMixed TopicsGastrointestinal CancerHead & Neck/Thyroid CancersGynecologic CancerGenitourinary Cancer
Oncology PracticeAI holds its own against pathologists for prostate cancer diagnosisJanuary 18, 2022Preventive CareGenitourinary CancerBusiness of Medicine
Oncology PracticeExperts disappointed by NICE’s decision to reject prostate cancer drugJanuary 6, 2022Genitourinary Cancer
Oncology PracticeFor equality in prostate cancer outcomes, seek equality in treatmentJanuary 3, 2022Genitourinary Cancer
Oncology PracticeCancer risk tied to some manufactured foodsDecember 16, 2021Breast CancerMetastatic Breast CancerGenitourinary Cancer
Oncology PracticeRare GU cancers: Overcoming obstacles through collaboration, novel trial designDecember 14, 2021Genitourinary Cancer
Oncology PracticeLGBTQ health care: There is reason to be hopefulDecember 7, 2021Diversity in MedicineGynecologic CancerGenitourinary Cancer
Oncology PracticeAfter doc uproar, NCCN reverses prostate cancer guidanceDecember 1, 2021Genitourinary Cancer
Oncology PracticeShock, disbelief as NCCN changes prostate cancer guidanceNovember 15, 2021Genitourinary Cancer
Oncology PracticeUrine test for prostate cancer signals amount of aggressive tumorNovember 11, 2021Genitourinary CancerProstate Cancer
Oncology PracticeProstate cancer risk higher with Lynch syndrome variantsNovember 8, 2021Genitourinary Cancer
